Back
Context Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
66
CNTX
Context Therapeutics
Last Price:
2.25
Seasonality Move:
-29.9%
Sell
25
NBY
NovaBay Pharmaceuticals
Last Price:
0.62
Seasonality Move:
-14.79%
Buy
66
Context Therapeutics (CNTX)
is a Buy
Is Context Therapeutics a Buy, Sell or Hold?
- The current Context Therapeutics [CNTX] share price is $2.22. The Score for CNTX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- CNTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.50. The Score for NBY is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CNTX Stock Price Chart
What is Context Therapeutics's stock price today?
-
The Context Therapeutics share price today is $2.22
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.50
The current trend is relatively stagnant and NBY is experiencing slight selling pressure.
CNTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 48.11 | Sell |
| Chaikin Money Flow: | 35314 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.14 - 2.54) | Sell |
| Bollinger Bands (100): | (1.81 - 2.37) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 37.14 | Sell |
| Chaikin Money Flow: | -28552 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.47 - 0.53) | Sell |
| Bollinger Bands (100): | (0.58 - 3.38) | Sell |
CNTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.1 | Buy |
| 20-day SMA: | 2.29 | Sell |
| 50-day SMA: | 2.3 | Sell |
| 200-day SMA: | 1.62 | Buy |
| 8-day EMA: | 2.13 | Buy |
| 20-day EMA: | 2.23 | Sell |
| 50-day EMA: | 2.23 | Sell |
| 200-day EMA: | 1.78 | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.49 | Buy |
| 20-day SMA: | 0.49 | Buy |
| 50-day SMA: | 0.86 | Sell |
| 200-day SMA: | 3.79 | Sell |
| 8-day EMA: | 0.49 | Buy |
| 20-day EMA: | 0.53 | Sell |
| 50-day EMA: | 0.95 | Sell |
| 200-day EMA: | 8.34 | Sell |
Context Therapeutics Earnings Growth & CNTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.14 per share, and a decrease next year of $0.02 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Context Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||